Stockscreener 앱 받기
1.515
4.11%
-0.065
전일 마감가:
$1.58
열려 있는:
$1.58
하루 거래량:
442.65K
Relative Volume:
0.42
시가총액:
$20.09M
수익:
-
순이익/손실:
$-7.51M
주가수익비율:
-1.1477
EPS:
-1.32
순현금흐름:
$-8.02M
1주 성능:
-0.98%
1개월 성능:
-5.31%
6개월 성능:
+89.19%
1년 성능:
+101.73%
1일 변동 폭
$1.5001
$1.5999
1주일 범위
$1.46
$1.78
52주 변동 폭
$0.6506
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
명칭
Hoth Therapeutics Inc
전화
(646)756-2997
주소
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
HOTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.515 | 20.95M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-10-15 | 개시 | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc 주식(HOTH)의 최신 뉴스
Will Hoth Therapeutics Inc. stock maintain growth storyStop Loss & Free Weekly Watchlist of Top Performers - newser.com
Measuring Hoth Therapeutics Inc.’s beta against major indicesJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com
Chart based analysis of Hoth Therapeutics Inc. trendsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
What candlestick patterns are forming on Hoth Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Can momentum traders help lift Hoth Therapeutics Inc.Market Sentiment Summary & Risk Controlled Stock Pick Alerts - newser.com
How to forecast Hoth Therapeutics Inc. trends using time seriesMarket Rally & Reliable Breakout Forecasts - newser.com
Is Hoth Therapeutics Inc. stock entering bullish territoryJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
What valuation multiples suggest for Hoth Therapeutics Inc. stockMarket Movers & Fast Entry Momentum Trade Alerts - newser.com
What analysts say about Hoth Therapeutics Inc stockSector ETF Performance & Free High Yield Growth Strategies - earlytimes.in
Hoth Therapeutics shares climb after expanding AI partnership with NVIDIA - MSN
Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA By Investing.com - Investing.com Nigeria
Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA - Investing.com
Hoth Therapeutics rises as it expands AI push with Nvidia licenses - TradingView
Hoth Therapeutics expands AI capabilities with NVIDIA partnership By Investing.com - Investing.com Canada
Hoth Therapeutics expands artificial intelligence initiative, selects NVIDIA AI Enterprise platform - MarketScreener
Hoth Therapeutics expands AI capabilities with NVIDIA partnership - Investing.com
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform - MarketScreener
Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025 - WV News
Analyzing Hoth Therapeutics Inc. with multi timeframe chartsVolume Spike & Community Verified Swing Trade Signals - newser.com
Best data tools to analyze Hoth Therapeutics Inc. stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention - ADVFN
EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Epidemiology, Regulations, Pipeline Analysis Featuring Azitra, Hoth Therapeutics, and Lutris PharmaResearchAndMarkets.com - The AI Journal
About Us - FinancialContent
Is Hoth Therapeutics Inc a good long term investmentCandlestick Pattern Analysis & Free Exceptional Risk Adjusted Gains - earlytimes.in
What institutional flow reveals about Hoth Therapeutics Inc.Portfolio Value Summary & High Yield Stock Recommendations - newser.com
EGFR Inhibitors-Induced Skin Disorders Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lutris Pharma, Hoth Therapeutics, TWi Biotechnology - Barchart.com
Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com Nigeria
Hoth expands HT-001 development with patents for cancer therapy side effects By Investing.com - Investing.com South Africa
Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities - WV News
Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy - Yahoo Finance
Chart Watch: Can Hoth Therapeutics Inc stock double in the next year2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک
Bull Run: Will Hoth Therapeutics Inc benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - خودرو بانک
New Highs: Whats the MACD signal for Hoth Therapeutics IncWeekly Trend Recap & Proven Capital Preservation Tips - خودرو بانک
Risks Report: Whats the outlook for Hoth Therapeutics Incs sectorWeekly Trading Summary & Daily Price Action Insights - خودرو بانک
Market Review: Is NGVT a momentum stockMarket Weekly Review & Risk Controlled Swing Alerts - khodrobank.com
Is Hoth Therapeutics Inc benefiting from innovation trendsEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک
Market Outlook: Will Hoth Therapeutics Inc. announce a stock splitQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - خودرو بانک
Hoth Therapeutics Inc (HOTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):